Patents Assigned to RX3 PHARMACEUTICALS
  • Publication number: 20070218481
    Abstract: The invention provides a method for generating and selecting drug-sensitizing antisense DNA fragments. In one embodiment, the method includes identifying a gene of interest using knowledge of bacterial physiology, biochemistry, genetics, genomics, and other means. The method includes PCR amplification of a gene of interest using genomic DNA as a template; fragmentation of the DNA by sonication or other means; selecting DNA fragments no longer than 400 base pairs; ligating the DNA fragments into a suitable expression plasmid with a selectable marker; transforming the plasmids containing the DNA fragments into the organism from which the gene of interest originated; and selecting clones from transformed cells that show a phenotypic difference of the clone grown in the presence of the inducer relative to the phenotype in the absence of inducer.
    Type: Application
    Filed: December 8, 2006
    Publication date: September 20, 2007
    Applicant: RX3 PHARMACEUTICALS
    Inventors: Robert Haselbeck, Mark Hilgers, Karen Shaw, Vickie Brown-Driver, Kedar Gc, John M. Finn, Mark Stidham
  • Publication number: 20070178111
    Abstract: The present invention provides a pharmaceutical composition useful for treating bacterial infections in humans and animals which comprises administering to a human or animal in need thereof, an antibacterially effective combination of a ?-lactam antibiotic and an inhibitor of any bacterial peptidoglycan biosynthesis enzyme, especially GlmU, GlmU, MurA, MurB, MurC, MurD, MurE, MurF, MurG, MraY, and UppS.
    Type: Application
    Filed: December 8, 2006
    Publication date: August 2, 2007
    Applicant: RX3 PHARMACEUTICALS
    Inventors: Vickie Brown-Driver, Kedar GC, John Finn, Robert Haselbeck, Mark Hilgers, Karen Shaw, Mark Stidham